Professional Documents
Culture Documents
Biomedicines 1698879
Biomedicines 1698879
Biomedicines 1698879
Yunys Pérez-Betancourt 1, Rachel Zaia1, Marina Franchi Evangelista1, Rodrigo Tadeu Ribeiro, Bruno Murillo 4
Roncoleta1, Beatriz Ideriha Mathiazzi and Ana Maria Carmona-Ribeiro 1,* 5
1 Biocolloids Laboratory, Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São 6
Paulo 05508-000, Brazil; y.betancourt@usp.br (Y.P-B); rachelzaia@usp.br (R.Z); 7
marina.franchi.evangelista@usp.br (M.F.E); rodrigo@iq.usp.br (R.T.R); bruno.roncoleta@usp.br (B.M.R); 8
bemathi@usp.br (B.I.M). 9
* Correspondence: amcr@usp.br; Tel.: +55-011-3091-1887. 10
Abstract: In this work, gramicidin (Gr) nanoparticles (NPs) are characterized and combined with 11
poly (diallyldimethylammonium) chloride (PDDA) antimicrobial polymer to yield antimicrobial 12
dispersions active against Gram-positive and Gram-negative bacteria, and fungus. Gr/PDDA dis- 13
persions were prepared and characterized using dynamic light-scattering for sizing, zeta-potential 14
analysis and polydispersity determinations whereas activity was obtained from colony forming uni- 15
ties counting against the microbia. Hybrid dispersions in water remained stable for at least 24 h and 16
displayed complete microbicidal effect against Staphyloccoccus aureus and Candida albicans against 17
107 and 106 viable cells per mL, respectively. Gramicidin dispersions in water examined under scan- 18
ning electron microscopy showed the Gr NPs with diameters varying from 160-200 nm that dis- 19
played a milky aspect in the assay tube, typical of particles scattering the incident light. Upon addi- 20
tion of PDDA, the slightly negative charge of Gr NPs changed its sign to positive values. Conduct- 21
ance of the Gr/PDDA dispersions was due to PDDA and was not affected by the presence of the Gr 22
NPs, showing that the interaction between Gr NPs and PDDA was relatively weak. In comparison 23
to Gr inserted in cationic bilayers that also yielded broad spectrum activity, the effect of Gr/PDDA 24
was equally broad but more complete yielding a total loss of cell viability. 25
Keywords: antimicrobial peptide; antimicrobial cationic polymer; antimicrobial cationic lipid; na- 26
Citation: Lastname, F.; Lastname, F.; noparticles; supported cationic bilayer on silica with or without gramicidin; scanning electron mi- 27
Lastname, F. Title. Biomedicines 2022, croscopy; dynamic light scattering; broad spectrum of antimicrobial activity 28
10, x. https://doi.org/10.3390/xxxxx 29
2.1. Materials 67
D-glucose, poly (diallyldimethylammonium chloride) (PDDA) 35% w/v with very 68
low molecular weight (< 100,000) was obtained from Sigma (Steinheim, Germany), gram- 69
icidin D (a peptide mixture consisting mostly of Gr A), ethanol, chloroform, 2,2,2-trifluo- 70
roethanol (TFE) and Mueller-Hinton agar (MHA) were purchased from Sigma-Aldrich (St 71
Louis, MO, USA). Dioctadecyldimethylammonium bromide (DODAB) and KCl were pur- 72
chased from Sigma (St. Louis, MO, USA). Silica (AEROSIL OX-50) was purchased from 73
Degussa (Frankfurt, Germany). The mean particle diameter determined by the supplier 74
using transmission electron microscopy (TEM) was 50 nm. Specific surface area was 75
Biomedicines 2022, 10, x FOR PEER REVIEW 3 of 15
2.6. Determination of circular dichroism spectra for gramicidin in ethanol, trifluoroethanol, water 150
and poly (diallyldimethylammonium) chloride solutions. 151
Spectra were acquired at 25°C using a 720 Spectropolarimeter (Jasco Inc, Tokyo, Ja- 152
pan) in a 0.1 cm quartz cell with 0.5 nm wavelength increments and a 4-second response 153
in the 200–280 nm range (at a 100 nm per minute scan rate). Each spectrum is the average 154
of five scans, with a full-scale sensitivity of 10 m deg. All spectra were corrected for back- 155
ground by subtraction of appropriate blanks in the absence of Gr (PDDA solution or Gr 156
solvent). Spectra smoothing kept the overall spectral shape. The ellipticities θ (in deg 157
dmol−1 cm2) were plotted as a function of wavelength. 158
2.8. Determination of cell viability for Staphylococcus aureus and Candida albicans over a range 165
of gramicidin or gramicidin /poly (diallyldimethylammonium chloride or 166
dioctadecyldimethylammonium bromide concentrations. 167
Staphylococcus aureus American Type Culture Collection (ATCC) 29213 or Candida al- 168
bicans (ATCC 90028) were cultured from previously frozen stocks (kept at −20 °C in the 169
appropriate storage medium). Each microorganism was reactivated separately, seeded by 170
streaking technique on the plates of Mueller-Hinton agar (MHA), and incubated for 18– 171
24 h at 37 °C. Isolated colonies were suspended in an isotonic 0.264 M D-glucose solution 172
and the turbidity of either bacteria or fungus suspensions was adjusted according to tube 173
0.5 of the McFarland scale at 625 nm. The 0.264 M D-glucose solution was used instead of 174
Biomedicines 2022, 10, x FOR PEER REVIEW 5 of 15
any culture medium because cationic molecules are inactivated by the relatively high ionic 175
strength or negatively charged molecules, such as amino acids and polysaccharides. For 176
the determination of cell viability, 0.1 mL of the cell suspensions (around 10 7–108 colony- 177
forming unities per mL, CFU.mL−1) were mixed with 0.9 mL of NPs dispersions diluted in 178
the same D-glucose solution for 1 h interaction. Thereafter, aliquots of 0.1 mL were with- 179
drawn and either directly plated or diluted 10 to 10 6 times before plating on MHA plates. 180
The plates were incubated at 37 °C for 24 h. The colony forming unities (CFU) counting 181
per mL was plotted in a logarithmic scale as a function of concentration of the antimicro- 182
bial agent. When no counting was obtained, since the log function does not exist for zero, 183
the CFU counting per mL was taken as 1 so that log CFU.mL−1 was zero. 184
TFE in water - - - 13 ± 2 0
Biomedicines 2022, 10, x FOR PEER REVIEW 6 of 15
0.1 mM Gr/0.25 mg/mL PDDA/TFE/water 426 ± 31 0.24 ± 0.04 49 ± 1 236 ± 6 0.64 ± 0.01
210
Figure 1 shows the effect of Gr concentration on the physical properties of Gr disper- 211
sions. With exception of the first point at a very low Gr concentration (0.005 mM), Dz and 212
zeta-potential for the Gr nanoparticles increased with Gr concentration. Therefore, in- 213
creasing the number of Gr molecules in the nanoparticle might have increased not only 214
their sizes but also the negative charges available for colloidal stabilization. This stability 215
was favored not only by the negative charges but also by the nature of formyl and ethan- 216
olamine moieties that are covalently bound to the two ends of the Gr molecule. These 217
moieties have the possibility of forming hydrogen bonds with water and are possibly oc- 218
cupying the outer surface of the Gr nanoparticle. The origin of the negative charges in the 219
otherwise neutral Gr molecule can only be the dissociation of hydroxyl in the phenyl moi- 220
ety of tyrosine (amino-acid residue at the 11th position of the molecule). One should notice 221
that terminal or lateral carboxylic groups are absent in the Gr primary structure. The hy- 222
droxyl dissociation in the phenyl moiety of tyrosine might have derived from the close 223
association between Gr molecules required for forming the Gr nanoparticles. The Gr in- 224
termolecular aggregation would be responsible for exposure of the phenyl tyrosine moi- 225
ety to the water phase. At this point one cannot avoid to propose a molecular dynamics 226
simulation study as a possible effective tool to ascertain the driving forces for Gr aggre- 227
gation in water. 228
Polydispersity (P) for the Gr dispersions remained constant as a function of Gr con- 229
centration revealing a good colloidal stability and lack of aggregation in between nano- 230
particles (Figure 1). Taking this result in combination with the increase in particle size (Dz) 231
upon increasing Gr concentration reveals that the increase in Dz is due to increase in the 232
number of Gr molecules in each nanoparticle instead of interparticle aggregation. The 233
measurement at 0.005 mM Gr performed at unfavorable condition of too low light scat- 234
tering was the less reliable one, possibly reflecting a condition where the Gr nanoparticles 235
were not formed yet. 236
237
Biomedicines 2022, 10, x FOR PEER REVIEW 7 of 15
238
Figure 1. Effect of gramicidin (Gr) concentration on physical properties of Gr dispersions in water. 239
Measurements were performed 30 minutes after preparation of the dispersions and contained 1% 240
of trifluoroethanol. Physical properties were the mean z-average diameter (Dz), the zeta-potential 241
(ζ), the polydispersity (P) and the conductance (G). 242
243
Figure 2 shows the effect of increasing [PDDA] over a range of [PDDA] (0 -0.1 244
mg/mL) at 0.05 mM Gr on Dz, P, zeta-potentials and conductance of the Gr/PDDA disper- 245
sions. In addition, the photos evidence the turbid but dispersed nature of the Gr/PDDA 246
dispersions in pure water. In absence of PDDA, the Gr dispersions of NPs exhibit a slightly 247
negative zeta-potential that was easily reversed at tiny amounts of PDDA. The mean zeta- 248
potential of Gr/PDDA in the dispersions was positive (Figure 2). Conductance increased 249
linearly with [PDDA]. 250
Biomedicines 2022, 10, x FOR PEER REVIEW 8 of 15
251
Figure 2. Effect of poly (diallyldimethyl ammonium chloride) (PDDA) concentration on macro- 252
scopic aspect and physical properties of gramicidin (Gr) /PDDA dispersions at 0.05 mM Gr. Physical 253
properties were the mean z-average diameter (Dz), the zeta-potential (ζ), the polydispersity (P) and 254
the conductance (G). 255
256
The colloid stability of Gr/PDDA dispersions was assessed from dynamic light scat- 257
tering and turbidity at 400 nm measurements over 24 h showing their stable character 258
(Figure 3). 259
Biomedicines 2022, 10, x FOR PEER REVIEW 9 of 15
260
Figure 3. Colloidal stability of gramicidin (Gr) nanoparticles in the absence or in the presence of 261
poly (diallyldimethyl ammonium chloride) (PDDA). Mean z-average diameter (Dz), zeta-potential 262
(ζ), polydispersity (P) and turbidity at 400 nm (Abs 400 nm) of gramicidin (Gr) nanoparticles in 263
water or in 0.05 mg/mL PDDA as a function of time. 264
265
In order to gain some insight into the secondary structure or conformation of the Gr 266
peptide in the Gr/PDDA dispersions, the circular dichroism spectra of Gr in different me- 267
dia were obtained. The peptide Gr assumes an intertwined conformation in ethanol and 268
a beta-helix turn in TFE. In the Gr NPs without or with PDDA, there was a significant 269
reduction in intensity of the circular dichroism of the Gr molecules, possibly due to their 270
tight packing in the Gr NPs. In addition, the Gr spectra in Gr NPs or in Gr/PDDA were 271
more similar to Gr spectrum in TFE possibly corresponding to some residual beta-helix 272
conformation for Gr individual molecules in the Gr NPs or Gr NPs/PDDA dispersions. 273
274
275
Figure 4. Circular dichroism spectra of 0.02 mM gramicidin (Gr) at 25 °C in different media. Aliquots 276
(0.02 mL) of Gr stock solutions (6.4 mM) in trifluoroethanol (TFE) or ethanol were added to 2.0 mL 277
of water, TFE or ethanol. Alternatively, aliquots of poly (diallyldimethyl ammonium chloride) 278
Biomedicines 2022, 10, x FOR PEER REVIEW 10 of 15
(PDDA) stock solution (10 mg/mL) were added to Gr dispersion under stirring by vortexing to yield 279
0.01, 0.02 and 0.05 mg/mL PDDA. 280
281
The SEM micrographs for Gr dispersions in water confirmed the occurrence of spherical NPs 282
for Gr dispersions (Figure 5a) and for Gr/PDDA dispersions (Figure 5b). 283
303
Figure 6. Conductance of a 0.05 mM gramicidin (Gr) dispersion in the absence (∆) or in the presence 304
of poly (diallyldimethyl ammonium chloride) (PDDA) (□). The control for conductance of PDDA 305
solutions in absence of Gr was performed over a range of [PDDA] (o). 306
In order to gain some insight on the relative efficacy of Gr formulations developed in 307
our group over the last decades against S. aureus, a comparison between different Gr for- 308
mulations involving or not the cationic antimicrobial lipid DODAB and its supported or 309
non-supported bilayers was presented on Figure 7. 310
Biomedicines 2022, 10, x FOR PEER REVIEW 11 of 15
311
Figure 7. Cell viability of Staphylococcus aureus (107 –108 CFU/mL) after interacting for 1 h with gram- 312
icidin (Gr) nanoparticles or other Gr formulations with dioctadecyldimethylammonium bromide 313
(DODAB) bilayers. Cell viability in the presence of DODAB supported bilayers on silica (SiO2 314
/DODAB/Gr), on polystyrene sulfate (PSS) nanoparticles (PSS/DODAB/Gr) [21], DODAB BF [20] or 315
DODAB bilayer fragments (DODAB BF) [13], all of them incorporating Gr]. In the DODAB BF dis- 316
persions, Gr dimers in the channel conformation were previously described [13,21]. The 317
SiO2/DODAB/Gr stock dispersion was prepared at 2 mg/mL silica, 0.5 mM DODAB and 0.05 mM 318
gramicidin yielding Dz=280±5 nm, P=0.20± 0.02 and ζ=45±4. 319
320
The cationic lipid bilayer of DODAB, similarly to the cationic polymer PDDA, bears 321
quaternary ammonium moieties well known for their activity against Gram-negative bac- 322
teria but yielding a poor performance against Gram-positive ones such as S. aureus. In- 323
serting Gr dimeric channels in DODAB bilayers prepared as DODAB bilayer fragments 324
did not improve very much the activity against S. aureus (Figure 7); Gr dimeric channels 325
found a very appropriate microenvironment in the DODAB bilayer and did not leave this 326
comfortable situation to interact with the coccus [13,21]. On the other hand, using sup- 327
ported DODAB bilayers on PSS NPs [21,40] or on silica [36] with Gr in the bilayers im- 328
proved significantly the activity against S. aureus (Figure 7]. In this work, the best formu- 329
lation against S. aureus was achieved, namely, the Gr NPs (Figure 7). There was a complete 330
loss of cell viability against this Gram-negative bacterium. 331
On Figure 8, the Gr NPs combined with PDDA were evaluated against S. aureus 332
showing also a complete loss of cell viability, similarly to the one obtained with Gr NPs 333
only. PDDA by itself had previously been investigated and did not cause a complete loss 334
of viability against S. aureus [23]. 335
Biomedicines 2022, 10, x FOR PEER REVIEW 12 of 15
336
Figure 8. Cell viability of Staphylococcus aureus (106 –108 CFU/mL) after interacting for 1 h with gram- 337
icidin (Gr) nanoparticles, PDDA/Gr nanoparticles or PDDA solutions over a range of Gr and/or 338
PDDA concentrations. Data for cell viability over a range of [PDDA] were reproduced from [23]. 339
340
On Figure 9, Gr NPs, PDDA and Gr NPs/PDDA dispersions were tested against Can- 341
dida albicans. In this case, the results showed the efficacy of Gr NPs and Gr NPs/ PDDA 342
against the fungus at very low Gr and PDDA concentrations. Testing immobilized Gr in 343
gold coatings a 90% reduction of fungus viability was reported [41]. For Gr NPs, the com- 344
plete loss of C. albicans viability on Figure 9 shows that Gr molecules are readily available 345
to interact with the fungus from the Gr NPs. The combined action of Gr NPs and PDDA 346
caused an even more lethal effect on the fungus than the effect of Gr only showing that 347
the cationic polymer is possibly paving the way of the antimicrobial peptide to the fungus 348
cell membrane across its brush cell wall [42]. 349
350
351
Figure 9. Cell viability of C. albicans (106 CFU/mL) after interacting for 1 h with gramicidin (Gr) 352
nanoparticles, PDDA/Gr nanoparticles or poly (diallyl dimethyl ammonium chloride) (PDDA) so- 353
lutions over a range of Gr and/or PDDA concentrations. Data for cell viability over a range of 354
[PDDA] were reproduced from [23]. 355
5. Conclusions 356
Biomedicines 2022, 10, x FOR PEER REVIEW 13 of 15
The particulate nature of gramicidin D dispersions in pure water was revealed from 357
sizing, zeta-potential, polydispersity, scanning electron microscopy and colloid stability 358
analysis. Given the high activity of Gr against Gram-positive bacteria and low activity 359
against Gram-negative ones, here successful combinations of Gr NPs with the cationic 360
antimicrobial polymer PDDA were shown to broaden the spectrum of antimicrobial ac- 361
tivity effectively causing complete loss of cell viability against 106 -108 cells/mL over 1 h 362
interaction time between dispersions and microbia (S. aureus and C. albicans). In addition, 363
Gr NPs dispersions advantageously compared with other Gr formulations in supported 364
or non –supported cationic bilayers showing the higher availability of Gr to interact with 365
the microbia from the Gr NPs as compared to the Gr/ cationic bilayer formulations. 366
367
Author Contributions: Conceptualization, A.M.C-R; methodology, Y.P.-B., R.Z., M.F.E., R.T.R., 368
B.M.R., B.M.I.; formal analysis, A.M.C-R.; investigation, Y.P.-B., R.Z., M.F.E., R.T.R., B.M.R., B.M.I, 369
A.M.C-R; resources, A.M.C-R; data curation, A.M.C-R.; writing—original draft preparation, A.M.C- 370
R and Y.P-B; writing—review and editing, A.M.C-R.; supervision, A.M.C-R; project administration, 371
A.M.C-R; funding acquisition, A.M.C-R. All authors have read and agreed to the published version 372
of the manuscript. 373
Funding: This research was funded by Conselho Nacional de Desenvolvimento Científico e Tecno- 374
lógico (CNPq), grants 302758/2019-4 and 302352/2014-7, and by Fundação de Amparo à Pesquisa do 375
Estado de São Paulo (FAPESP), grant 2019/17685-2. 376
Data Availability Statement: All data available are reported in the article. 379
Acknowledgments: Y.P.-B. was the recipient of a Ph.D. fellowship from CNPq (grant 140091/2019- 380
0). B.M.R. is the recipient of an undergraduate technician TT-1 fellowship from FAPESP (grant 381
2021/01245-3) and R.Z. is the recipient of the Programa Unificado de Bolsas (PUB) from Univer- 382
sidade de São Paulo (USP) granted to the project Antimicrobial Nanoparticles and their Films by 383
A.M.C-R. 384
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the 385
design of the study; in the collection, analyses, or interpretation of data; in the writing of the manu- 386
script, or in the decision to publish the results. 387
References 388
1. Urry D. W.; Goodall M. C.; Glickson J. D.; Mayers D. F. The Gramicidin A Transmembrane Channel: Characteristics of Head- 389
to-Head Dimerized π(L,D) Helices. Proceedings of the National Academy of Sciences 1971, 68, 1907–1911, doi:10.1073/pnas.68.8.1907. 390
2. Kelkar, D.A.; Chattopadhyay, A. Modulation of Gramicidin Channel Conformation and Organization by Hydrophobic 391
Mismatch in Saturated Phosphatidylcholine Bilayers. Biochimica et Biophysica Acta (BBA)-Biomembranes 2007, 1768, 1103–1113. 392
3. Veatch, W.R.; Fossel, E.T.; Blout, E.R. Conformation of Gramicidin A. Biochemistry 1974, 13, 5249–5256. 393
4. Kelkar, D.A.; Chattopadhyay, A. The Gramicidin Ion Channel: A Model Membrane Protein. Biochimica et Biophysica Acta (BBA)- 394
5. Svensson, F.R.; Lincoln, P.; Nordén, B.; Esbjörner, E.K. Tryptophan Orientations in Membrane-Bound Gramicidin and 396
Melittin—a Comparative Linear Dichroism Study on Transmembrane and Surface-Bound Peptides. Biochimica et Biophysica Acta 397
6. Hu, W.; Lee, K.; Cross, T. Tryptophans in Membrane Proteins: Indole Ring Orientations and Functional Implications in the 399
7. Koeppe, R.; Anderson, O. Engineering the Gramicidin Channel. Annual review of biophysics and biomolecular structure 1996, 25, 401
231–258. 402
Biomedicines 2022, 10, x FOR PEER REVIEW 14 of 15
8. Lundbæ k, J.A.; Collingwood, S.A.; Ingólfsson, H.I.; Kapoor, R.; Andersen, O.S. Lipid Bilayer Regulation of Membrane Protein 403
Function: Gramicidin Channels as Molecular Force Probes. Journal of The Royal Society Interface 2010, 7, 373–395. 404
9. Carvalho, C.A.; Olivares-Ortega, C.; Soto-Arriaza, M.A.; Carmona-Ribeiro, A.M. Interaction of Gramicidin with 405
DPPC/DODAB Bilayer Fragments. Biochimica et biophysica acta 2012, 1818, 3064–3071, doi:10.1016/j.bbamem.2012.08.008. 406
10. Carmona-Ribeiro, A.M. The Versatile Dioctadecyldimethylammonium Bromide. In Application and Characterization of 407
Surfactants; Najjar, R., Ed.; IntechOpen, 2017; pp. 157–182 ISBN 978-953-51-3326-1. 408
11. Wang, F.; Qin, L.; Pace, C.J.; Wong, P.; Malonis, R.; Gao, J. Solubilized Gramicidin A as Potential Systemic Antibiotics. 409
12. Pavithrra, G.; Rajasekaran, R. Gramicidin Peptide to Combat Antibiotic Resistance: A Review. International Journal of Peptide 411
13. Ragioto, D.A.M.T.; Carrasco, L.D.M.; Carmona-Ribeiro, A.M. Novel Gramicidin Formulations in Cationic Lipid as Broad- 413
Spectrum Microbicidal Agents. International journal of nanomedicine 2014, 9, 3183–3192, doi:10.2147/IJN.S65289. 414
14. Roscia, G.; Falciani, C.; Bracci, L.; Pini, A. The Development of Antimicrobial Peptides as New Antibacterial Drugs. Curr Protein 415
15. Urban, B.W.; Hladky, S.B.; Haydon, D.A. Ion Movements in Gramicidin Pores. An Example of Single-File Transport. Biochim 417
16. Moretta, A.; Scieuzo, C.; Petrone, A.M.; Salvia, R.; Manniello, M.D.; Franco, A.; Lucchetti, D.; Vassallo, A.; Vogel, H.; Sgambato, 419
A.; et al. Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields. Frontiers in Cellular and Infection Microbiology 420
17. Magana, M.; Pushpanathan, M.; Santos, A.L.; Leanse, L.; Fernandez, M.; Ioannidis, A.; Giulianotti, M.A.; Apidianakis, Y.; 422
Bradfute, S.; Ferguson, A.L.; et al. The Value of Antimicrobial Peptides in the Age of Resistance. Lancet Infect Dis 2020, 20, e216–e230, 423
doi:10.1016/S1473-3099(20)30327-3. 424
18. Martins, L.M.S.; Mamizuka, E.M.; Carmona-Ribeiro, A.M. Cationic Vesicles as Bactericides. Langmuir 1997, 13, 5583–5587, 425
doi:10.1021/la970353k. 426
19. Campanha, M.T.; Mamizuka, E.M.; Carmona-Ribeiro, A.M. Interactions between Cationic Liposomes and Bacteria: The 427
Physical-Chemistry of the Bactericidal Action. Journal of lipid research 1999, 40, 1495–1500. 428
20. Mathiazzi, B.I.; Carmona-Ribeiro, A.M. Hybrid Nanoparticles of Poly (Methyl Methacrylate) and Antimicrobial Quaternary 429
21. Xavier, G.R.S.; Carmona-Ribeiro, A.M. Cationic Biomimetic Particles of Polystyrene/Cationic Bilayer/Gramicidin for Optimal 431
22. Carmona-Ribeiro, A.M.; de Melo Carrasco, L.D. Cationic Antimicrobial Polymers and Their Assemblies. International journal 433
23. Sanches, L.M.; Petri, D.F.S.; de Melo Carrasco, L.D.; Carmona-Ribeiro, A.M. The Antimicrobial Activity of Free and 435
Immobilized Poly (Diallyldimethylammonium) Chloride in Nanoparticles of Poly (Methylmethacrylate). Journal of nanobiotechnology 436
24. Carmona-Ribeiro, A.M.; Araújo, P.M. Antimicrobial Polymer−Based Assemblies: A Review. International Journal of Molecular 438
25. Kruk, T.; Gołda-Cępa, M.; Szczepanowicz, K.; Szyk-Warszyńska, L.; Brzychczy-Włoch, M.; Kotarba, A.; Warszyński, P. 440
Nanocomposite Multifunctional Polyelectrolyte Thin Films with Copper Nanoparticles as the Antimicrobial Coatings. Colloids and 441
26. Kayitmazer, A.B.; Strand, S.P.; Tribet, C.; Jaeger, W.; Dubin, P.L. Effect of Polyelectrolyte Structure on Protein-Polyelectrolyte 443
Coacervates: Coacervates of Bovine Serum Albumin with Poly(Diallyldimethylammonium Chloride) versus Chitosan. 444
27. Wang, X.; Zheng, K.; Si, Y.; Guo, X.; Xu, Y. Protein-Polyelectrolyte Interaction: Thermodynamic Analysis Based on the Titration 446
28. Pérez-Betancourt, Y.; Távora, B.C.L.F.; Colombini, M.; Faquim-Mauro, E.L.; Carmona-Ribeiro, A.M. Simple Nanoparticles from 448
the Assembly of Cationic Polymer and Antigen as Immunoadjuvants. Vaccines 2020, 8, doi:10.3390/vaccines8010105. 449
29. Borro, B.C.; Malmsten, M. Complexation between Antimicrobial Peptides and Polyelectrolytes. Advances in Colloid and Interface 450
30. Rodríguez López, A. de L.; Lee, M.-R.; Ortiz, B.J.; Gastfriend, B.D.; Whitehead, R.; Lynn, D.M.; Palecek, S.P. Preventing S. 452
Aureus Biofilm Formation on Titanium Surfaces by the Release of Antimicrobial β-Peptides from Polyelectrolyte Multilayers. Acta 453
31. Nicolas, M.; Beito, B.; Oliveira, M.; Tudela Martins, M.; Gallas, B.; Salmain, M.; Boujday, S.; Humblot, V. Strategies for 455
Antimicrobial Peptides Immobilization on Surfaces to Prevent Biofilm Growth on Biomedical Devices. Antibiotics 2022, 11, 456
doi:10.3390/antibiotics11010013. 457
32. Melo, L.D.; Mamizuka, E.M.; Carmona-Ribeiro, A.M. Antimicrobial Particles from Cationic Lipid and Polyelectrolytes. 458
Langmuir : the ACS journal of surfaces and colloids 2010, 26, 12300–12306, doi:10.1021/la101500s. 459
33. Carrasco, L.D. de M.; Sampaio, J.L.M.; Carmona-Ribeiro, A.M. Supramolecular Cationic Assemblies against Multidrug- 460
Resistant Microorganisms: Activity and Mechanism of Action. International journal of molecular sciences 2015, 16, 6337–6352, 461
doi:10.3390/ijms16036337. 462
34. Rapuano, Renata.; Carmona-Ribeiro, A.M. Physical Adsorption of Bilayer Membranes on Silica. Journal of colloid and interface 463
35. Moura, S.P.; Carmona-Ribeiro, A.M. Cationic Bilayer Fragments on Silica at Low Ionic Strength: Competitive Adsorption and 465
36. Ribeiro, R.T.; Braga, V.H.A.; Carmona-Ribeiro, A.M. Biomimetic Cationic Nanoparticles Based on Silica: Optimizing Bilayer 467
Deposition from Lipid Films. Biomimetics (Basel, Switzerland) 2017, 2, doi:10.3390/biomimetics2040020. 468
37. Nascimento, D.B.; Rapuano, R.; Lessa, M.M.; Carmona-Ribeiro, A.M. Counterion Effects on Properties of Cationic Vesicles. 469
38. Grabowski, E.; Morrison, I. Particle Size Distribution from Analysis of Quasi-Elastic Light Scattering Data. In Measurement of 471
Suspended Particles by Quasi-elastic Light Scattering; Dahneke, B., Ed.; New York, 1983; pp. 199–236. 472
39. Zhou, Y.; Franks, G.V. Flocculation Mechanism Induced by Cationic Polymers Investigated by Light Scattering. Langmuir : the 473
ACS journal of surfaces and colloids 2006, 22, 6775–6786, doi:10.1021/la060281+. 474
40. Carmona-Ribeiro, A.M.; Midmore, B.R. Synthetic Bilayer Adsorption onto Polystyrene Microspheres. Langmuir 1992, 8, 801– 475
41. Yala, J.-F.; Thebault, P.; Héquet, A.; Humblot, V.; Pradier, C.-M.; Berjeaud, J.-M. Elaboration of Antibiofilm Materials by 477
Chemical Grafting of an Antimicrobial Peptide. Appl Microbiol Biotechnol 2011, 89, 623–634, doi:10.1007/s00253-010-2930-7. 478
42. Carmona-Ribeiro, A.M.; Carrasco, L.D.M. Fungicidal Assemblies and Their Mode of Action. OA Biotechnol 2013, 2, 25–25. 479
480
481